A comparative analysis of FDA inspections in EU, China and India shows higher inspection coverage leads to lower rates of manufacturing violations. During 2010-15, the number of FDA inspections of Indian companies more than doubled to 270 from 108, indicating tighter regulatory oversight. Almost a ...
Read more: Drug makers can now expect more regular checkups from USFDA